Rasio utang jangka cendhak marang ekuitas: Harmony Biosciences (HRMY)
Harmony Biosciences (HRMY) is a reputable biopharmaceutical player developing effective therapies for orphan diseases of the nervous system. This daily price chart reflects the dynamics of an asset with a value of 0.09. Demand for unique medications is rising due to an expanding list of diagnoses. The brand's financial stability is based on payments from insurance companies and government funds supporting individuals with narcolepsy and cataplexy.
Rincian metrik keuangan lan pasar harmonybiosciences.com (HRMY)
- kuotasi lan prakiraan analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data liabilitas lan likuiditas perusahaan:
Total Utang marang Modal Harmony Biosciences|HRMY - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal Harmony Biosciences Holdings, Inc.|HRMY - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Harmony Biosciences Inc|HRMY - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Harmony Biosciences|Likuiditas cepet harmonybiosciences.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
Analisis komprehensif perusahaan:HRMY Harmony Pharma
This indicator assesses the company's dependence on short-term liabilities relative to its equity, allowing for the determination of liquidity risk or the degree of aggressive expansion. A stable short-term debt-to-equity ratio confirms the ability of Harmony Biosciences (HRMY) to fund its premium elite pharmacologist fund using internal resources, which minimizes credit shocks and strengthens the fundamental resilience of the business.
Pesaing langsung
Utang jangka cendhak marang modal BIIB|NBIX - Kewajiban jangka cendhak marang modal|Regencell Bioscience - Rasio utang jangka cendhak marang ekuitas|Utang jangka cendhak marang modal axsome.com AXSM|ACAD - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal XENE (Xenon Pharmaceuticals Inc.)|Viking Pharma (VKTX) - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang modal Supernus Corp (SUPN)|CPRX (Catalyst Pharmaceuticals) - Utang jangka cendhak marang modal|DNLI: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal BHVN|Utang jangka cendhak marang modal Amylyx Pharmaceuticals Inc (AMLX)|Utang jangka cendhak marang ekuitas Trevi Pharma TRVI|Rasio tanggungan utang jangka cendhak marang modal PRAX|AVXL - Utang jangka cendhak marang ekuitas|ceribell.com (CBLL) - Rasio utang jangka cendhak marang ekuitas|Prothena Corp (PRTA) - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang modal Alector (ALEC)|Utang jangka cendhak marang ekuitas Annexon Inc.|Rasio utang jangka cendhak marang modal OMER (Omeros Corp.)|Rasio utang jangka cendhak marang ekuitas NGNE (Neurogene Inc.)|ACIU - Kewajiban jangka cendhak marang modal|Voyager Therapeutics, Inc. - Rasio utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal NMRA|Scilex Holding Co. - Utang jangka cendhak marang modal|TVGN: Utang jangka cendhak marang ekuitas|ACOG: Utang jangka cendhak marang modal|CGTX - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Inhibikase Therapeutics, Inc.|Kewajiban jangka cendhak marang modal Cassava Sciences Inc SAVA|Utang jangka cendhak marang ekuitas Assertio Holdings, Inc. (ASRT)|Koefisien utang jangka cendhak marang modal coyatherapeutics.com|Utang jangka cendhak marang modal VTGN (Vistagen)|OVID - Rasio utang jangka cendhak marang ekuitas|Acumen Pharmaceuticals, Inc. - Utang jangka cendhak marang modal|Koefisien utang jangka cendhak marang modal CervoMed, Inc. CRVO|ATHE: Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Clene (CLNN)|Utang jangka cendhak marang ekuitas PepGen Inc|Rasio utang jangka cendhak marang modal JUNS (jupiterneurosciences.com)|Utang jangka cendhak marang modal RLMD|Rasio utang jangka cendhak marang ekuitas Annovis Bio Inc ANVS|Utang jangka cendhak marang modal GRCE (Grace Therapeutics)|Firefly Neuro (AIFF) - Kewajiban jangka cendhak marang modal|KLTO - Utang jangka cendhak marang ekuitas|Koefisien utang jangka cendhak marang modal NeuroSense Therapeutics NRSN|RVPH: Utang jangka cendhak marang modal|MetaVia - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas NeurAxis, Inc|HSDT: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Passage Bio, Inc. (PASG)|Rasio utang jangka cendhak marang ekuitas bionomics.com.au NEUP|Minerva Neurosciences, Inc. - Rasio utang jangka cendhak marang ekuitas|Athira Pharma Inc (ATHA) - Kewajiban jangka cendhak marang modal|ADXN - Utang jangka cendhak marang ekuitas|ALZN (Alzamend Neuro, Inc.) - Rasio utang jangka cendhak marang modal|CYCN: Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Protagenic Therapeutics, Inc. (PTIX)|Rasio utang jangka cendhak marang ekuitas KTTA|Utang jangka cendhak marang modal Cortigent Medical|Utang jangka cendhak marang ekuitas Avenue Therapeutics, Inc (ATXI)|BCLI (BrainStorm Cell Therapeutics Inc.) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Cara Therapeutics, Inc. CARA|chromocell.com (CHRO) - Kewajiban jangka cendhak marang modal|Eliem - Utang jangka cendhak marang modal|Rasio tanggungan utang jangka cendhak marang modal ITCI (Intra-Cellular Therapies)|LBPH: Utang jangka cendhak marang modal|Marinus Pharma (MRNS) - Utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas NKGen Biotech, Inc.|NRBO: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Sage Therapeutics (SAGE)|Rasio utang jangka cendhak marang ekuitas Synaptogenix Inc. SNPX|Utang jangka cendhak marang ekuitas Trevena, Inc TRVN|Vigil Neuroscience Inc. (VIGL) - Kewajiban jangka cendhak marang modal|WENA - Utang jangka cendhak marang ekuitas|CERE (cerevel.com) - Rasio utang jangka cendhak marang modal